
In young children, recent changes to WHO guidelines for starting anti-AIDS drugs (antiretroviral therapy—ART) are unlikely to improve death rates but may increase the numbers of children receiving ART by simplifying access to treatment.
This is according to a study by international researchers published in this week's PLOS Medicine.
Advertisement
The findings from a study, led by Michael Schomaker from the University of Cape Town in South Africa, suggest that, among southern African children aged 2-5 years at HIV diagnosis, there was no difference in three year death rates between children in whom ART was started immediately and those in whom starting ART was deferred until their CD4 count and percentage (markers of progression of HIV infection) fell below 750 cells/mm3 and 25% respectively.
The authors reached these conclusions by using information from almost 3000 2-5 year old children with HIV who enrolled for ARV treatment in HIV clinics in South Africa, Malawi, and Zimbabwe to develop a model. From this model, the authors found that if all children had started ART immediately after diagnosis irrespective of CD4 value (2013 WHO guidelines) the estimated combined death rate would be 2.1% but if ART was started at a CD4 count below 750 cells/mm3 or a CD4% below 25% (2010 WHO guidelines) the figure was 2.2%, a statistically non-significant difference. However, the authors found higher death rates when ART was started at lower CD4 counts and the study is limited by lack of clinical information on the children and loss of follow up.
The authors conclude: "Our results indicate that in children aged 2-5 y in southern Africa, there is no difference in mortality between starting ART immediately and deferring until CD4% drops below 25% or CD4 count drops below 750 cells/mm3."
Source: Eurekalert
The authors conclude: "Our results indicate that in children aged 2-5 y in southern Africa, there is no difference in mortality between starting ART immediately and deferring until CD4% drops below 25% or CD4 count drops below 750 cells/mm3."
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest AIDS/HIV News

In India, annual HIV infections and AIDS-related deaths continue to drop. Between 2010 and 2021, new HIV infections dropped by 46%.

Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.

How can you prevent HIV while breastfeeding? A monthly vaginal ring containing the antiretroviral drug dapivirine safely prevents HIV infection while breastfeeding.

Union Minister of State for Health Bharti Pravin Pawar had said that the government is providing free lifelong antiretroviral (ARV) medicines for people living with HIV.

Dr. Korosi said the goal to end AIDS by 2030 is badly off track, as inequalities, discrimination, and disregard for human rights are hampering our progress.